Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
NASA Astronaut Jonny Kim to Speak at Harvard in June
The American Navy SEAL, born to immigrants, is a doctor and a space traveler.
Chan School of Public Health Department Chair Departs for UCLA
Kari Nadeau, an environmental health leader, will serve as the dean of the Fielding School of Public Health.
Trump Administration Sues Harvard over Civil Rights
The March 20 suit seeks to rescind research grants that were restored in an earlier court ruling.
Most popular
Explore More From Current Issue
The True Cost of Grade Inflation at Harvard
How an abundance of A’s created “the most stressed-out world of all.”
The Enterprise Research Campus in Allston Nears Completion
A hotel, restaurants, and other retail establishments are open or on the way.
